title: Brain natriuretic peptide measurement in pulmonary medicine.
abstract: Serum levels of natriuretic peptides are well established as important biomarkers in patients with cardiac disease. Less attention has been placed on the role of natriuretic peptides in patients with pulmonary conditions. In several well-defined groups of patients with pulmonary disease natriuretic peptides provide the clinician with clinically valuable information. A limitation of the interpretation of natriuretic peptides in pulmonary disease is the confounding effect of concurrent conditions such as heart failure, hypoxia, sepsis and renal failure. The present paper reviews the role of natriuretic peptides for diagnosis, risk stratification and prognosis of several pulmonary disorders.
authors.affiliation: Tulane University Health Sciences Center, Department of Medicine, Section of Pulmonary Diseases, Critical Care and Environmental Medicine, 1430 Tulane Avenue, Office 204, New Orleans, LA 70112, USA. dsalerno@tulane.edu
authors.forename: Daniel
authors.initials: D
authors.lastname: Salerno
authors.forename: Paul E
authors.initials: PE
authors.lastname: Marik
mesh_terms: D015415:Biomarkers / Q000097:blood; D015897:Comorbidity; D006801:Humans; D008171:Lung Diseases / Q000097:blood* / Q000175:diagnosis* / Q000453:epidemiology; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D011379:Prognosis; D018570:Risk Assessment; D012307:Risk Factors
chemical_list: D015415:Biomarkers; D020097:Natriuretic Peptide, Brain